Description
Lysozyme from Human Sputum
| Catalog number: | B2019045 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 1 mg |
| Molecular Weight or Concentration: | N/A |
| Supplied as: | Powder |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | RT |
| Keywords: | Lysozyme, Human Sputum (Sterilized) |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Wine JJ, Joo NS, Choi JY, Cho HJ, Krouse ME, Wu JV, Khansaheb M, Irokawa T, Ianowski J, Hanrahan JW, Cuthbert AW, Tran KV. Measurement of fluid secretion from intact airway submucosal glands Methods Mol Biol. 2011;742:93-112.
- Konstan MW, Chen PW, Sherman JM, Thomassen MJ, Wood RE, Boat TF. Human lung lysozyme: sources and properties Am Rev Respir Dis. 1981 Jan;123(1):120-4.
- Pang G, Clancy R, Cong M, Ortega M, Zhigang R, Reeves G. Influenza virus inhibits lysozyme secretion by sputum neutrophils in subjects with chronic bronchial sepsis Am J Respir Crit Care Med. 2000 Mar;161(3 Pt 1):718-22.
- Jenssen AO, Smidsrd O, Harbitz O. The importance of lysozyme for the viscosity of sputum from patients with chronic obstructive lung disease Scand J Clin Lab Invest. 1980;40(8):727-31.
- Ohbayashi H, Setoguchi Y, Fukuchi Y, Shibata K, Sakata Y, Arai T. Pharmacological effects of lysozyme on COPD and bronchial asthma with sputum: A randomized, placebo-controlled, small cohort, cross-over study Pulm Pharmacol Ther. 2016 Apr;37:73-80.
- Sibila O, Perea L, Cant E, Shoemark A, Cassidy D, Smith AH, Suarez-Cuartin G, Rodrigo-Troyano A, Keir HR, Oriano M, Ong S, Vidal S, Blasi F, Aliberti S, Chalmers JD. Antimicrobial peptides, disease severity and exacerbations in bronchiectasis Thorax. 2019 Sep;74(9):835-842.
- Fukuchi Y, Tatsumi K, Inoue H, Sakata Y, Shibata K, Miyagishi H, Marukawa Y, Ichinose M. Prevention of COPD exacerbation by lysozyme: a double-blind, randomized, placebo-controlled study Int J Chron Obstruct Pulmon Dis. 2016 Apr 21;11:831-8.
- Harbitz O, Jenssen AO, Smidsrd O. Lysozyme and lactoferrin in sputum from patients with chronic obstructive lung disease Eur J Respir Dis. 1984 Oct;65(7):512-20.
- Aggarwal AN, Gupta D, Jindal SK. Diagnosis of tuberculous pleural effusion Indian J Chest Dis Allied Sci. 1999 Apr-Jun;41(2):89-100.
